1. Home
  2. RAMP vs AGIO Comparison

RAMP vs AGIO Comparison

Compare RAMP & AGIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RAMP
  • AGIO
  • Stock Information
  • Founded
  • RAMP 2018
  • AGIO 2007
  • Country
  • RAMP United States
  • AGIO United States
  • Employees
  • RAMP N/A
  • AGIO N/A
  • Industry
  • RAMP EDP Services
  • AGIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • RAMP Technology
  • AGIO Health Care
  • Exchange
  • RAMP Nasdaq
  • AGIO Nasdaq
  • Market Cap
  • RAMP 2.2B
  • AGIO 2.0B
  • IPO Year
  • RAMP 1987
  • AGIO 2013
  • Fundamental
  • Price
  • RAMP $31.25
  • AGIO $35.22
  • Analyst Decision
  • RAMP Buy
  • AGIO Buy
  • Analyst Count
  • RAMP 6
  • AGIO 7
  • Target Price
  • RAMP $39.33
  • AGIO $56.33
  • AVG Volume (30 Days)
  • RAMP 527.9K
  • AGIO 621.1K
  • Earning Date
  • RAMP 02-05-2025
  • AGIO 02-13-2025
  • Dividend Yield
  • RAMP N/A
  • AGIO N/A
  • EPS Growth
  • RAMP N/A
  • AGIO N/A
  • EPS
  • RAMP 0.00
  • AGIO 11.64
  • Revenue
  • RAMP $728,708,000.00
  • AGIO $36,498,000.00
  • Revenue This Year
  • RAMP $14.29
  • AGIO $166.22
  • Revenue Next Year
  • RAMP $8.61
  • AGIO $98.36
  • P/E Ratio
  • RAMP $26,105.13
  • AGIO $3.03
  • Revenue Growth
  • RAMP 14.50
  • AGIO 36.07
  • 52 Week Low
  • RAMP $21.45
  • AGIO $27.14
  • 52 Week High
  • RAMP $38.00
  • AGIO $62.58
  • Technical
  • Relative Strength Index (RSI)
  • RAMP 36.27
  • AGIO 54.02
  • Support Level
  • RAMP $33.33
  • AGIO $33.25
  • Resistance Level
  • RAMP $34.04
  • AGIO $34.86
  • Average True Range (ATR)
  • RAMP 1.04
  • AGIO 1.33
  • MACD
  • RAMP -0.45
  • AGIO 0.37
  • Stochastic Oscillator
  • RAMP 1.33
  • AGIO 97.99

About RAMP LiveRamp Holdings Inc.

LiveRamp Holdings Inc is a global technology company that helps companies build enduring brand and business value by collaborating responsibly with data. A groundbreaking leader in consumer privacy, data ethics and foundational identity, LiveRamp offers a connected customer view with clarity and context while protecting brand and consumer trust.

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company with a focus on developing treatments geared towards cancer and rare genetic disorders of metabolism. The company's primary focus is to develop potentially transformative small-molecule medicines. The clinical development plan for Agios' product candidates includes a precision approach with initial study designs that allow for genetically or biomarker-defined patient populations. The company seeks the potential for proof of concept early in clinical development, along with any potential for accelerated approval.

Share on Social Networks: